Greg Pyszczymuka, Chief Commerical Officer at AYTU BIOPHARMA, INC (AYTU), bought 12,000 shares at $1.87 ($22K) on 2023-06-16, disclosed to the SEC on 2023-06-20.
Open-market purchase of $22k AYTU by Chief Commerical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.